MTOR and metabolic dysfunction-associated steatotic liver disease: On the other hand, dysregulated mTOR signaling in NAFLD can prevent TFEB from moving to the nucleus, which lowers autophagy and compromises lysosomal function (Lavallard and Gual 2014).